| Nov 1 |
Alnylam Pharmaceuticals Third Quarter 2024 Earnings: EPS Beats Expectations, Revenues Lag
|
| Nov 1 |
Alnylam Pharmaceuticals Inc (ALNY) Q3 2024 Earnings Call Highlights: Strong Revenue Growth and ...
|
| Nov 1 |
Decoding Alnylam Pharmaceuticals Inc (ALNY): A Strategic SWOT Insight
|
| Nov 1 |
Q3 2024 Alnylam Pharmaceuticals Inc Earnings Call
|
| Oct 31 |
Alnylam Pharmaceuticals, Inc. 2024 Q3 - Results - Earnings Call Presentation
|
| Oct 31 |
Alnylam Pharmaceuticals, Inc. (ALNY) Q3 2024 Earnings Call Transcript
|
| Oct 31 |
Alnylam (ALNY) Reports Q3 Earnings: What Key Metrics Have to Say
|
| Oct 31 |
Alnylam Pharmaceuticals (ALNY) Reports Q3 Loss, Lags Revenue Estimates
|
| Oct 31 |
Alnylam: Q3 Earnings Snapshot
|
| Oct 31 |
Alnylam Pharmaceuticals Non-GAAP EPS of -$0.50 misses by $0.11, revenue of $500.92M misses by $26.1M
|
